lomitapide
Selected indexed studies
- Lomitapide. (, 2012) [PMID:31643777]
- Lomitapide. (, 2006) [PMID:29999690]
- Lomitapide. (Am J Cardiovasc Drugs, 2011) [PMID:21846156]
_Worker-drafted node — pending editorial review._
Connections
lomitapide is a side effect of
Sources
- Lomitapide. (2012) pubmed
- Lomitapide. (2006) pubmed
- Lomitapide. (2011) pubmed
- Lomitapide: navigating cardiovascular challenges with innovative therapies. (2024) pubmed
- Lomitapide for the treatment of hypercholesterolemia. (2017) pubmed
- Lomitapide for the treatment of pediatric homozygous familial hypercholesterolemia. (2025) pubmed
- Lomitapide for the treatment of paediatric patients with homozygous familial hypercholesterolaemia (APH-19): results from the efficacy phase of an open-label, multicentre, phase 3 study. (2024) pubmed
- Lomitapide repurposing for treatment of malignancies: A promising direction. (2024) pubmed
- Lomitapide-a Microsomal Triglyceride Transfer Protein Inhibitor for Homozygous Familial Hypercholesterolemia. (2020) pubmed
- Lomitapide and Mipomersen-Inhibiting Microsomal Triglyceride Transfer Protein (MTP) and apoB100 Synthesis. (2019) pubmed